Cargando…
Real-world outcomes of COVID-19 treatment with remdesivir in a Spanish hospital
Remdesivir is the only antiviral approved for lower respiratory tract infection produced by SARS-CoV-2. The main objective of this study was to determine the mortality rate, readmissions, mean hospital stay, need for higher levels of oxygen support, and adverse effect-induced abandonment rate in hos...
Autores principales: | Hidalgo-Tenorio, Carmen, García-Vallecillos, Coral, Sequera-Arquelladas, Sergio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448042/ https://www.ncbi.nlm.nih.gov/pubmed/34664862 http://dx.doi.org/10.1097/MD.0000000000027228 |
Ejemplares similares
-
Rildo: Real-World Multicenter Study on the Effectiveness and Safety of Single-Tablet Regimen of Dolutegravir plus Rilpivirine in Treatment-Experienced People Living with HIV
por: Hidalgo-Tenorio, Carmen, et al.
Publicado: (2022) -
Timing in antibiotic therapy: when and how to start, de-escalate and stop antibiotic therapy. Proposals from a stablished antimicrobial stewardship program
por: Pasquau-Liaño, Juan, et al.
Publicado: (2022) -
The changing epidemiology of tuberculosis in a Spanish tertiary hospital (1995–2013)
por: González-García, Andrés, et al.
Publicado: (2017) -
Clinical and Microbiological Profile of a Retrospective Cohort of Enteric Fever in 2 Spanish Tertiary Hospitals
por: Sánchez-Montalvá, Adrián, et al.
Publicado: (2015) -
Real-world assessment of the effectiveness of posaconazole for the prophylaxis and treatment of invasive fungal infections in hematological patients: A retrospective observational study
por: Chen, Xiaochen, et al.
Publicado: (2021)